BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6404503)

  • 1. Apomorphine-induced changes in local cerebral blood flow in normal rats and after lesions of the dopaminergic nigrostriatal bundle.
    Ingvar M; Lindvall O; Stenevi U
    Brain Res; 1983 Mar; 262(2):259-65. PubMed ID: 6404503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of methamphetamine on blood flow in the caudate-putamen after lesions of the nigrostriatal dopaminergic bundle in the rat.
    Lindvall O; Ingvar M; Stenevi U
    Brain Res; 1981 Apr; 211(1):211-6. PubMed ID: 7225839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supersensitivity of presynaptic receptors involved in the dopaminergic control of striatal high affinity glutamate uptake after 6-hydroxydopamine lesion of nigrostriatal dopaminergic neurons.
    Kerkerian L; Nieoullon A
    Exp Brain Res; 1988; 69(2):424-30. PubMed ID: 2894320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions.
    Dunnett SB; Björklund A; Stenevi U; Iversen SD
    Brain Res; 1981 Dec; 229(2):457-70. PubMed ID: 6796197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotational behaviour induced by theophylline in 6-OHDA nigrostriatal denervated rats is dependent on the supersensitivity of striatal dopaminergic receptors.
    Casas M; Ferré S; Cadafalch J; Grau JM; Jané F
    Pharmacol Biochem Behav; 1989 Jul; 33(3):609-13. PubMed ID: 2511576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of muscarinic receptors in the rat caudate-putamen after lesioning of the ipsilateral nigrostriatal dopamine pathway with 6-hydroxydopamine (6-OHDA): normalization by fetal mesencephalic transplants.
    Dawson TM; Dawson VL; Gage FH; Fisher LJ; Hunt MA; Wamsley JK
    Brain Res; 1991 Feb; 540(1-2):145-52. PubMed ID: 1905173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurological basis of motor asymmetry following unilateral nigrostriatal lesions in the rat: the effect of secondary superior colliculus lesions.
    Crossman AR; Sambrook MA
    Brain Res; 1978 Dec; 159(1):211-3. PubMed ID: 569529
    [No Abstract]   [Full Text] [Related]  

  • 11. Injections of 6-hydroxydopamine in the substantia nigra of the rat brain: morphological and biochemical effects.
    Buonamici M; Cervini MA; Rossi AC; Sebastiani L; Raffaelli A; Bagnoli P
    Behav Brain Res; 1990 Apr; 38(1):83-95. PubMed ID: 2112003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasticity of [14C]2-deoxy-D-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement.
    Kozlowski MR; Marshall JF
    Brain Res; 1980 Sep; 197(1):167-83. PubMed ID: 7397550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of lesion-induced dopaminergic supersensitivity using the rotational model in the mouse.
    Mandel RJ; Randall PK
    Brain Res; 1985 Mar; 330(2):358-63. PubMed ID: 3921193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between motor asymmetry and direction of rotational behaviour under amphetamine and apomorphine in rats with unilateral degeneration of the nigrostriatal dopamine system.
    Ziegler MG; Szechtman H
    Behav Brain Res; 1990 Jul; 39(2):123-33. PubMed ID: 2390196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat.
    Floran B; Aceves J; Sierra A; Martinez-Fong D
    Neurosci Lett; 1990 Aug; 116(1-2):136-40. PubMed ID: 2147981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opponent-process theory and drug conditioning: an assessment for conditioned stimulant-induced movement.
    Carey RJ; Damianopoulos EN
    Behav Brain Res; 1992 Nov; 51(2):139-47. PubMed ID: 1466780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.